These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 33805628)
1. Doxorubicin Encapsulation in Carbon Nanotubes Having Haeckelite or Stone-Wales Defects as Drug Carriers: A Molecular Dynamics Approach. Contreras L; Villarroel I; Torres C; Rozas R Molecules; 2021 Mar; 26(6):. PubMed ID: 33805628 [TBL] [Abstract][Full Text] [Related]
2. Carbon Nanotubes Having Haeckelite Defects as Potential Drug Carriers. Molecular Dynamics Simulation. Torres C; Villarroel I; Rozas R; Contreras L Molecules; 2019 Nov; 24(23):. PubMed ID: 31771295 [TBL] [Abstract][Full Text] [Related]
3. Preparation and properties of carbon nanotube (Fe)/hydroxyapatite composite as magnetic targeted drug delivery carrier. Li H; Sun X; Li Y; Li B; Liang C; Wang H Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():222-229. PubMed ID: 30678906 [TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics insight of interaction between the functionalized-carbon nanotube and cancerous cell membrane in doxorubicin delivery. Kordzadeh A; Zarif M; Amjad-Iranagh S Comput Methods Programs Biomed; 2023 Mar; 230():107332. PubMed ID: 36603233 [TBL] [Abstract][Full Text] [Related]
5. Adsorption and encapsulation of the drug doxorubicin on covalent functionalized carbon nanotubes: A scrutinized study by using molecular dynamics simulation and quantum mechanics calculation. Kordzadeh A; Amjad-Iranagh S; Zarif M; Modarress H J Mol Graph Model; 2019 May; 88():11-22. PubMed ID: 30616088 [TBL] [Abstract][Full Text] [Related]
6. Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma. Chaudhuri P; Soni S; Sengupta S Nanotechnology; 2010 Jan; 21(2):025102. PubMed ID: 19955607 [TBL] [Abstract][Full Text] [Related]
7. Understanding the co-loading and releasing of doxorubicin and paclitaxel using chitosan functionalized single-walled carbon nanotubes by molecular dynamics simulations. Karnati KR; Wang Y Phys Chem Chem Phys; 2018 Apr; 20(14):9389-9400. PubMed ID: 29565091 [TBL] [Abstract][Full Text] [Related]
8. Carbon Nanotubes: An Emerging Drug Delivery Carrier in Cancer Therapeutics. Panigrahi BK; Nayak AK Curr Drug Deliv; 2020; 17(7):558-576. PubMed ID: 32384030 [TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulation study of doxorubicin adsorption on functionalized carbon nanotubes with folic acid and tryptophan. Arabian T; Amjad-Iranagh S; Halladj R Sci Rep; 2021 Dec; 11(1):24210. PubMed ID: 34930942 [TBL] [Abstract][Full Text] [Related]
10. Anticancer DOX delivery system based on CNTs: Functionalization, targeting and novel technologies. Yaghoubi A; Ramazani A J Control Release; 2020 Nov; 327():198-224. PubMed ID: 32763433 [TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulation of doxorubicin adsorption on a bundle of functionalized CNT. Izadyar A; Farhadian N; Chenarani N J Biomol Struct Dyn; 2016 Aug; 34(8):1797-805. PubMed ID: 26375507 [TBL] [Abstract][Full Text] [Related]
12. Description of Release Process of Doxorubicin from Modified Carbon Nanotubes. Chudoba D; Jażdżewska M; Łudzik K; Wołoszczuk S; Juszyńska-Gałązka E; Kościński M Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769431 [TBL] [Abstract][Full Text] [Related]
13. Pegylated and folic acid functionalized carbon nanotubes as pH controlled carriers of doxorubicin. Molecular dynamics analysis of the stability and drug release mechanism. Wolski P; Nieszporek K; Panczyk T Phys Chem Chem Phys; 2017 Mar; 19(13):9300-9312. PubMed ID: 28323298 [TBL] [Abstract][Full Text] [Related]
14. Carbon nanotubes as an emerging nanocarrier for the delivery of doxorubicin for improved chemotherapy. Chadar R; Afzal O; Alqahtani SM; Kesharwani P Colloids Surf B Biointerfaces; 2021 Dec; 208():112044. PubMed ID: 34419810 [TBL] [Abstract][Full Text] [Related]
15. A new family of folate-decorated and carbon nanotube-mediated drug delivery system: synthesis and drug delivery response. Huang H; Yuan Q; Shah JS; Misra RD Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1332-9. PubMed ID: 21514336 [TBL] [Abstract][Full Text] [Related]
16. In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin. Thakur CK; Martins FG; Karthikeyan C; Bhal S; Kundu CN; Moorthy NSHN; Sousa SF J Mol Model; 2024 Jul; 30(8):261. PubMed ID: 38985223 [TBL] [Abstract][Full Text] [Related]
17. Study of folate-based carbon nanotube drug delivery systems targeted to folate receptor α by molecular dynamic simulations. Jiang Y; Wang C; Zhang M; Liu L; Gao X; Zhang S; Ye D Int J Biol Macromol; 2023 Jul; 244():125386. PubMed ID: 37327924 [TBL] [Abstract][Full Text] [Related]
18. pH-Sensitive Co-Adsorption/Release of Doxorubicin and Paclitaxel by Carbon Nanotube, Fullerene, and Graphene Oxide in Combination with Rezaian M; Maleki R; Dahri Dahroud M; Alamdari A; Alimohammadi M Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30380660 [TBL] [Abstract][Full Text] [Related]
19. TRPV1 channel as a target for cancer therapy using CNT-based drug delivery systems. Ortega-Guerrero A; Espinosa-Duran JM; Velasco-Medina J Eur Biophys J; 2016 Jul; 45(5):423-33. PubMed ID: 26872481 [TBL] [Abstract][Full Text] [Related]
20. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes. Mehra NK; Jain NK J Drug Target; 2013 Sep; 21(8):745-58. PubMed ID: 23822734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]